Steven Ruchefsky

Fondateur chez Regel Therapeutics Inc.

Profil

Steven B.
Ruchefsky founded Regel Therapeutics Inc. in 2020, where he is working as President, Chief Executive Officer & Director from 2020.
Mr. Ruchefsky also currently works at MD SolarSciences Corp., as Executive Chairman, Lantibio, Inc., as Director, Canoil, Inc., as Director, SCRIPT Biosciences, Inc., as Director, HitchBio, Inc., as President, Secretary, Treasurer & Director, Commercial Street Capital LLC, as President from 2010, and Phifund Managers, LLC, as Partner.
Mr. Ruchefsky also formerly worked at National Investment Managers, Inc., as Director from 2005 to 2012, Energy Pioneer Solutions, Inc., as Director, Evogene Ltd., as Director, Itamar Medical Ltd., as Director, Arno Therapeutics, Inc., as Director from 2010 to 2014, Kite Pharma, Inc., as Independent Director from 2014 to 2017, GH Group, Inc., as Director, Morrison Cohen LLP, as Partner, Caremi Partners Ltd., as Principal, and JEN Partners LLC, as Advisory Committee Member from 2010 to 2013.
Mr. Ruchefsky received his graduate degree from George Washington University Law School.

Postes actifs de Steven Ruchefsky

Sociétés	Poste	Début
Lantibio, Inc.	Directeur/Membre du Conseil	19/03/2010
Canoil, Inc.	Directeur/Membre du Conseil	19/03/2010
Commercial Street Capital LLC	President	01/01/2010
MD SolarSciences Corp.	Président	-
Regel Therapeutics Inc.	Fondateur	01/01/2020
Phifund Managers, LLC	Private Equity Investor	-
Script Biosciences, Inc.	Directeur/Membre du Conseil	-
HitchBio, Inc.	President	-

Anciens postes connus de Steven Ruchefsky

Sociétés	Poste	Fin
KITE PHARMA INC	Directeur/Membre du Conseil	03/10/2017
░░░░░░ ░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	-
░░ ░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	-
░░░░░░░░ ░░░░░ ░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-
░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	-

Formation de Steven Ruchefsky

George Washington University Law School

Graduate Degree